×
Mesa Laboratories EBIT 2010-2025 | MLAB
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Mesa Laboratories ebit from 2010 to 2025. Ebit can be defined as earnings before interest and taxes.
View More
Mesa Laboratories EBIT 2010-2025 | MLAB
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Mesa Laboratories ebit from 2010 to 2025. Ebit can be defined as earnings before interest and taxes.
Related Stocks
Company Name
Market
Cap
Thermo Fisher Scientific (TMO)
$184.3B
Intuitive Surgical (ISRG)
$168.9B
IDEXX Laboratories (IDXX)
$51.3B
Edwards Lifesciences (EW)
$47.5B
Alcon (ALC)
$40.1B
IQVIA Holdings (IQV)
$32.1B
DexCom (DXCM)
$30B
Mettler-Toledo (MTD)
$26.5B
STERIS (STE)
$24.5B
Waters (WAT)
$17.5B
SONOVA HOLDING (SONVY)
$17B
Hologic (HOLX)
$14.8B
Penumbra (PEN)
$10.4B
Globus Medical (GMED)
$8.3B
Sysmex ADR (SSMXY)
$8.1B
Masimo (MASI)
$7.7B
Teleflex (TFX)
$5.7B
Glaukos (GKOS)
$5.5B
TransMedics (TMDX)
$4B
Integer Holdings (ITGR)
$3.8B
LivaNova (LIVN)
$3.1B
Alphatec Holdings (ATEC)
$2.4B
PROCEPT BioRobotics (PRCT)
$2.3B
Veracyte (VCYT)
$2.3B
Artivion (AORT)
$2.1B
Nihon Kohden (NHNKY)
$1.9B
Elekta AB (EKTAY)
$1.9B
Integra LifeSciences Holdings (IART)
$1.2B
OPKO Health (OPK)
$1.1B
Paragon 28 (FNA)
$1.1B